SM

Scott W. Martin

BS Bristol-Myers Squibb: 23 patents #194 of 3,969Top 5%
📍 Middletown, CT: #22 of 449 inventorsTop 5%
🗺 Connecticut: #1,653 of 34,797 inventorsTop 5%
Overall (All Time): #179,907 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
11964973 Substituted bicyclic compounds useful as T cell activators Robert G. Gentles, Upender Velaparthi, Min Ding, Richard E. Olson, Saumya Roy +4 more 2024-04-23
11866430 Naphthyridinone compounds useful as T cell activators Louis S. Chupak, Min Ding, Robert G. Gentles, Yazhong Huang, Ivar M. McDonald +5 more 2024-01-09
11713316 Substituted naphthyridinone compounds useful as T cell activators Upender Velaparthi, Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles +16 more 2023-08-01
10954238 Substituted naphthyridinone compounds useful as T cell activators Upender Velaparthi, Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles +16 more 2021-03-23
10669272 Substituted naphthyridinone compounds useful as T cell activators Upender Velaparthi, Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles +16 more 2020-06-02
9850225 Compounds useful as immunomodulators Louis S. Chupak, Min Ding, Xiaofan Zheng, Piyasena Hewawasam, Timothy P. Connolly +5 more 2017-12-26
8143243 Compounds for the treatment of hepatitis C Carl P. Bergstrom, Robert G. Gentles, Kap-Sun Yeung 2012-03-27
8133884 Compounds for the treatment of hepatitis C Carl P. Bergstrom, Min Ding, Xiaofan Zheng, Robert G. Gentles 2012-03-13
7652004 Compounds for the treatment of hepatitis C Carl P. Bergstrom, Robert G. Gentles, Kap-Sun Yeung 2010-01-26
7642251 Compounds for the treatment of hepatitis C Carl P. Bergstrom 2010-01-05
7521441 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Robert G. Gentles, Piyasena Hewawasam, Min Ding, Carl P. Bergstrom, Kap-Sun Yeung +4 more 2009-04-21
7473688 Indolobenzazepine HCV NS5B inhibitors Carl P. Bergstrom, John A. Bender, Robert G. Gentles, Piyasena Hewawasam, Thomas W. Hudyma +6 more 2009-01-06
7456165 HCV NS5B inhibitors Carl P. Bergstrom, Thomas W. Hudyma 2008-11-25
7348425 Inhibitors of HCV replication Thomas W. Hudyma, Xiaofan Zheng, Feng He, Min Ding, Carl P. Bergstrom +2 more 2008-03-25
7183302 Iminothiazolidinones as inhibitors of HCV replication Jeffrey Lee Romine, Lawrence B. Snyder, Michael H. Serrano-Wu, Milind Deshpande, Darren Whitehouse +4 more 2007-02-27
7153848 Inhibitors of HCV replication Thomas W. Hudyma, Xiaofan Zheng, Feng He, Min Ding, Carl P. Bergstrom +2 more 2006-12-26
7112601 Cycloalkyl heterocycles for treating hepatitis C virus Peter W. Glunz, Brent Douty, Jeffrey Lee Romine 2006-09-26
6479482 Alkylamine derivatives of dihydropyridine NPY antagonists Graham S. Poindexter, Marc Bruce, Sing-Yuen Sit 2002-11-12
6271249 Diphenyl imidazoles as potassium channel modulators Jeffrey Lee Romine, Piyasena Hewawasam, Nicholas A. Meanwell, Valentin Gribkoff, John E. Starrett, Jr. 2001-08-07
6077861 Diphenyl triazoles as potassium channel modulators Jeffrey Lee Romine, Piyasena Hewawasam, Nicholas A. Meanwell, Valentin Gribkoff, John E. Starrett, Jr. 2000-06-20
5869509 Diphenyl oxadiazolones as potassium channel modulators Jeffrey Lee Romine, Piyasena Hewawasam, Nicholas A. Meanwell, Valentin Gribkoff, John E. Starrett, Jr. 1999-02-09
5380854 Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors Jeffrey Lee Romine, Nicholas A. Meanwell 1995-01-10
5254576 Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors Jeffrey Lee Romine, Nicholas A. Meanwell 1993-10-19